Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-01
2006-08-01
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S486000
Reexamination Certificate
active
07084168
ABSTRACT:
This invention relates to substituted indoline derivative compounds which are antagonists of the progesterone receptor, their preparation and pharmaceutical utility, particularly including contraception and treatment of benign or malignant neoplastic diseases, having the general structure:wherein R1and R2may be single substituents or fused to form spirocyclic rings.
REFERENCES:
patent: 3635964 (1972-01-01), Skorcz
patent: 3917592 (1975-11-01), Kobzina
patent: 4093730 (1978-06-01), Butti
patent: 4440785 (1984-04-01), Walsh
patent: 4617302 (1986-10-01), Robertson
patent: 4666913 (1987-05-01), Kubla
patent: 4670566 (1987-06-01), Walsh
patent: 4721721 (1988-01-01), Kuhla
patent: 4822794 (1989-04-01), Spada
patent: 4831027 (1989-05-01), Narr
patent: 4853473 (1989-08-01), Fischer
patent: 4933336 (1990-06-01), Martin
patent: 5007952 (1991-04-01), Kume
patent: 5171851 (1992-12-01), Kim
patent: 5182282 (1993-01-01), Clemence et al.
patent: 5300655 (1994-04-01), Ehrgott et al.
patent: 5414088 (1995-05-01), von der Saal
patent: 5447928 (1995-09-01), Williams
patent: 5453516 (1995-09-01), Fischer
patent: 5475020 (1995-12-01), Johnson
patent: 5521166 (1996-05-01), Grubb
patent: 5552412 (1996-09-01), Cameron
patent: 5565483 (1996-10-01), Hewawasam et al.
patent: 5576330 (1996-11-01), Buzzetti et al.
patent: 5659046 (1997-08-01), Kameswaran
patent: 5681817 (1997-10-01), Hodgen
patent: 5688808 (1997-11-01), Jones
patent: 5688810 (1997-11-01), Jones
patent: 5693646 (1997-12-01), Jones
patent: 5693647 (1997-12-01), Jones
patent: 5696127 (1997-12-01), Jones
patent: 5696130 (1997-12-01), Jones
patent: 5696133 (1997-12-01), Jones
patent: 5719136 (1998-02-01), Chwalisz
patent: 5733902 (1998-03-01), Schneider
patent: 5808139 (1998-09-01), Pathirana
patent: 5874430 (1999-02-01), Christ
patent: 5952511 (1999-09-01), Esaki et al.
patent: 6031111 (2000-02-01), Esaki et al.
patent: 6077840 (2000-06-01), Kurihara
patent: 6114536 (2000-09-01), Esaki et al.
patent: 6127544 (2000-10-01), Esaki et al.
patent: 6153622 (2000-11-01), Cameron
patent: 6204286 (2001-03-01), Cameron
patent: 6207836 (2001-03-01), Esaki et al.
patent: 6306851 (2001-10-01), Santilli
patent: 6319912 (2001-11-01), Grubb
patent: 6329416 (2001-12-01), Grubb
patent: 6339098 (2002-01-01), Collins
patent: 6355648 (2002-03-01), Fensome et al.
patent: 6358947 (2002-03-01), Zhi
patent: 6358948 (2002-03-01), Zhang
patent: 6369056 (2002-04-01), Zhang
patent: 6369086 (2002-04-01), Davis et al.
patent: 6380178 (2002-04-01), Grubb
patent: 6380235 (2002-04-01), Zhang
patent: 6387919 (2002-05-01), Davis et al.
patent: 6391907 (2002-05-01), Fensome
patent: 6399593 (2002-06-01), Grubb
patent: 6407101 (2002-06-01), Collins
patent: 6417214 (2002-07-01), Ullrich
patent: 6423699 (2002-07-01), Grubb
patent: 6436929 (2002-08-01), Zhang
patent: 6441019 (2002-08-01), Santilli
patent: 6441193 (2002-08-01), Cameron
patent: 6444668 (2002-09-01), Grubb
patent: 6462032 (2002-10-01), Grubb
patent: 6498154 (2002-12-01), Grubb
patent: 6503939 (2003-01-01), Grubb
patent: 6509334 (2003-01-01), Zhang et al.
patent: 6521657 (2003-02-01), Fensome et al.
patent: 6541503 (2003-04-01), Davis et al.
patent: 6544970 (2003-04-01), Grubb et al.
patent: 6562857 (2003-05-01), Collinstead
patent: 6566358 (2003-05-01), Zhang et al.
patent: 6566372 (2003-05-01), Zhi et al.
patent: 6583145 (2003-06-01), Fensome et al.
patent: 2001/0025051 (2001-09-01), Cameron
patent: 2002/0086874 (2002-07-01), Fensome et al.
patent: 2002/0094983 (2002-07-01), Zhang et al.
patent: 2002/0111355 (2002-08-01), Zhang et al.
patent: 2002/0115853 (2002-08-01), Zhang et al.
patent: 2002/0151531 (2002-10-01), Grubb et al.
patent: 2003/0008909 (2003-01-01), Ullrich et al.
patent: 2003/0045511 (2003-03-01), Grubb et al.
patent: 2003/0069430 (2003-04-01), Davis et al.
patent: 2003/0092711 (2003-05-01), Zhang et al.
patent: 2003/0130506 (2003-07-01), Zhi et al.
patent: 3633861 (1988-04-01), None
patent: 4330234 (1995-03-01), None
patent: 4344463 (1995-06-01), None
patent: 022317 (1981-01-01), None
patent: 208510 (1987-01-01), None
patent: 311135 (1989-04-01), None
patent: 385850 (1990-09-01), None
patent: 483077 (1991-09-01), None
patent: 454330 (1991-10-01), None
patent: 535529 (1992-09-01), None
patent: 510235 (1992-10-01), None
patent: 947507 (1999-10-01), None
patent: 978279 (2000-02-01), None
patent: P 95 02415 (1996-11-01), None
patent: P 00 04490 (2001-03-01), None
patent: 63112584 (1988-05-01), None
patent: 2067576 (1996-10-01), None
patent: N2073671 (1997-02-01), None
patent: 95121739 (1998-02-01), None
patent: N96111002 (1998-09-01), None
patent: WO86/03749 (1986-07-01), None
patent: WO91/04974 (1991-04-01), None
patent: WO91/06545 (1991-05-01), None
patent: WO93/12085 (1993-06-01), None
patent: WO94/14434 (1994-07-01), None
patent: WO94/29272 (1994-12-01), None
patent: WO95/11013 (1995-04-01), None
patent: WO95/20389 (1995-08-01), None
patent: WO95/20972 (1995-08-01), None
patent: WO95/33746 (1995-12-01), None
patent: WO96/15794 (1996-05-01), None
patent: WO96/19458 (1996-06-01), None
patent: WO96/19997 (1996-07-01), None
patent: WO97/13767 (1997-04-01), None
patent: WO97/49407 (1997-12-01), None
patent: WO98/14436 (1998-04-01), None
patent: WO98/27059 (1998-06-01), None
patent: WO9827059 (1998-06-01), None
patent: WO98/55116 (1998-12-01), None
patent: WO99/10325 (1999-03-01), None
patent: WO99/11264 (1999-03-01), None
patent: WO99/15500 (1999-04-01), None
patent: WO99/44608 (1999-09-01), None
patent: WO-01/15108 (2001-03-01), None
Golub et al., Science, 286, 531-537, 1999.
R. Evans, “The Steroid and Thyroid Hormone Receptor Superfamily”, Science, 240:889 (May 13, 1988).
A. Ulmann et al, “Clinical Uses of Mifepristone (MFP)”, Ann. N.Y. Acad. Sci., 261:248 (Jun. 12, 1995).
R. Kekkonen et al, “Sequential Regiment of the Antiprogesterone RU486 and Synthetic Progestin for Contraception”, Fertility and Sterility, 60(4):610 (Oct. 1993).
K. Horwitz et al, “Progestin, Progesterone Receptors, and Breast Cancer”, Horm. Cancer, publisher: Birkhaeuser, Boston, Mass., ed. Vedeckis, pp. 283-306 (1996) (abstract only).
A. Murphy et al, “Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU486”, J. Clin. Endo. Metab., 76(2):513 (Feb. 1993).
L. Kettel et al, “Endocrine Responses to Long-Term Administration of the Antiprogesterone RU486 in Patients with Pelvic Endometriosis”, Fertility and Sterility, 56(3):402 (Sep. 1991).
H. Michna et al, “Differentiation Therapy with Progesterone Antagonists”, Ann. N.Y. Acad. Sci., 761:224 (Jun. 1995).
L. Zhi et al, “5-Aryl-1,2-Dihydrochromeno[3,4-f]quinolines: A Novel Class of Nonsteroidal Human Progesterone Receptor Agonists”, J. Med. Chem., 41(3):291 (Oct. 22, 1998).
D. Combs et al, “Nonsteroidal Progesterone Receptor Ligands. 2. High-Affinity Ligands with Selectivity for Bone Cell Progesterone Receptors”, J. Med. Chem., 38:4880 (Dec. 8, 1995).
K. Perlman et al, “20-Oxopregnacalciferols: Vitamin D Compounds that Bind the Progesterone Receptor”, Tet. Letters, 35(15)2295 (1994).
L. Hamann et al, “Synthesis and Biological Activity of Novel Nonsteroidal Progesterone Receptor Antagonists”, Ann. N.Y. Acad. Sci., 761:383 (Jun. 12, 1995).
R. Chen et al, “Synthesis and SAR of a Novel Series of Spirobenzothlzaepine Derivatives with Antiprogestin Activity”, POI-37, 16thInt. Cong. Het. Chem., Montana (1997).
B. Narr et al, “Preparation, Testing, and Formulation of Imidazobenzoxazinones as Cardiotonics”, Chemical Abstracts, 109:22973 (1988).
R. Hartmann et al, “Effects of Brofoxine, A New Anxiolytic on Experimentally Induced Conflict in Rats”, Proc. West. Pharmacol. Soc., 21:51-55 (1978).
B. Singh et al, “Novel cAMP PDE III Inhibitor” Imidazo[4,5-b]pyridin-2(3H)-ones and Thiazolo[4,5-b]pyridin-2(3H)-ones and their Analogs, J. Med. Chem., 37:248 (Jan. 21, 1994).
A. Andreani et al, “Potential Antitumor Agents XVII (1). Cytotoxic Agents from Indole Derivatives and the
Bender Reinhold H.W.
Edwards James P.
Fensome Andrew
Jones Todd K.
Miller Lori L.
Howson and Howson
Powers Fiona T.
Wyeth
LandOfFree
Indoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3612175